Nephrology companies develop therapies, diagnostics and research technologies for diseases affecting the kidneys and renal system. Their work supports earlier detection, disease monitoring and the treatment of acute, chronic and inherited kidney conditions.
This category includes companies working on:
Browse 10 UK nephrology and kidney disease companies below.
AAV gene therapy platform targeting podocyte-mediated kidney disease
Purespring Therapeutics is a clinical-stage biotech developing AAV-based gene therapies for chronic kidney disease. Its platform delivers therapeutic transgenes directly to…
Blood-based liquid biopsy for endothelial glycocalyx and microvascular health
Dimension Biotechnologies is a biotech developing a rapid, blood-based diagnostic for microvascular health based on analysis of the endothelial glycocalyx, the molecular layer…
AI-driven drug discovery targeting necrosis and age-related disease
LinkGevity is a preclinical-stage biotechnology company developing anti-necrotic therapeutics for age-related and degenerative diseases. Founded in 2023 and based at Babraham…
FDA-approved AI blood test for diabetic kidney disease risk
Renalytix is an artificial intelligence-enabled in vitro diagnostics company focused on the clinical management of chronic kidney disease. Its blood-based test combines biomarker…
Specialist renal pharmaceuticals and clinical nutrition products
Stanningley Pharma is a specialty pharmaceutical company focused on products for patients with chronic kidney disease and other hospital medicine therapeutic areas. The company…
AI-driven precision therapeutics for metabolic syndrome diseases
Multiomic Health is a data-centric therapeutics company developing precision medicines for metabolic syndrome-related conditions, including type 2 diabetes, cardiovascular…
Small molecule therapeutics targeting PDE4 enzymes in kidney disease
Mironid is a company developing first-in-class small molecule therapeutics for autosomal dominant polycystic kidney disease, one of the most common hereditary kidney disorders.…
DUB inhibitor therapeutics targeting mitophagy and degenerative disease
Mission Therapeutics is a clinical-stage biotechnology company developing first-in-class small molecule inhibitors of deubiquitylating enzymes to treat diseases driven by…
Engineered macrophage cell therapy for inflammatory and fibrotic disease
Resolution Therapeutics is a clinical-stage biotech developing regenerative macrophage therapies for inflammatory and fibrotic diseases. Its platform harnesses the…
Independent global health research institute focused on chronic diseases
The George Institute for Global Health (UK) is an independent medical research institute conducting large-scale clinical trials, population studies, and health policy research on…